Women with early-stage breast cancer whose surgery has been postponed during the coronavirus pandemic need not worry about the delay, new study findings suggest.
A longer time from diagnosis to surgery doesn't affect overall survival of women with early-stage tumors, the researchers found. They also said a delay didn't lower survival among women with estrogen-sensitive, early-stage breast cancer who received neoadjuvant endocrine therapy before their surgery.
|